| SHENZHEN NEPTUNUS INTERLONG BIO-TECHNIQUE COMPANY LIMITED
236,670,000 of our company¡¯s stock in total are allocated at price of HKD 0.38-0.48. On 9th Sept 2005, share allocation result will be announced and expected share will be exchanged on HK Growth Enterprise Market in Hongkong Exchanges & Clearing Ltd (HKEx). Stock No. 8329
¡°With continuous development of biotechnology recent years, annual sales rate of global bio-technology drugs has grown and raised by 15%-33%. Development of our domestic bio-technologies is in accordance with that of international bio-technologies, seeing a pleasant future. Thanks to our continuous efforts, spirit of being bold in making innovations, and abundant experiences, our products brand and reputation in market are well built. With taking such a golden opportunity, we profoundly believe in our future success.¡± Said Mr. Zhang Simin, the President of Neputus Group.
In reality, investment on medical treatment and disease prevention in China is much lower than that in the developed country. Nevertheless flourish economic development is improving people¡¯s life and enhancing people awareness of healthy, and also population aging problem increasing the need of preventive or therapy drugs, these all bring infinite development opportunity to our domestic pharmaceutical industry.
¡°In order to meet the demand of expanding market and increasing production capacity and to keep in step with the current market trend, we conduct research of marketing and build up a GMP plant as a production base for new product (including influenza vaccine) in Shenzhen Guangming Hi-tech industrial zone. The construction of the new plant is expected to be completed in June of 2006. Look forward to the future, we will make constant efforts on research capability, offering high quality and multivariate biological products to meet market demands, and also actively exploit and expand oversea markets to bring greatest profit to our shareholders.¡± Said Mr. Chai, the General Manager of Neptunus Interlong. |
Your
Current position:
